Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF

被引:45
作者
Mei, FJ [1 ]
Ishizu, T [1 ]
Murai, H [1 ]
Osoegawa, M [1 ]
Minohara, M [1 ]
Zhang, KN [1 ]
Kira, J [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Neurol, Neurol Inst,Higashi Ku, Fukuoka 8128582, Japan
关键词
Th1; Th2; CSF; cytokine; CIDP; vasculitic neuropathy;
D O I
10.1016/j.jns.2004.10.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To investigate the intra- and extracellular levels of various cytokines and chemokines in CSF in chronic inflammatory demyelinating polyneuropathy (CIDP) and vasculitic neuropathy (VN), 16 cytokines, IL-1beta, IL-2, 11-4, IL-5, IL-6, IL-7, IL-8, IL-10, 11-12 (p70), IL-13, IL-17, IFN-gamma, TNF-alpha, G-CSF, MCP-1 and MIP-1beta, were measured in CSF supematant by a multiplexed fluorescent bead-based immunoassay and intracellular production of IFN-gamma and IL-4 in CSF CD4+ T cells were simultaneously measured by flow cylonveiry, in 14 patients with CIDP, 8 patients with VN and 25 patients with other noninflammatory neurologic diseases (OND). In the CSF supematant, a significant increase of IL-17, IL-8 and IL-6, and a significant decrease of 11-4. IL-5 and IL-7 levels were detected in pretreated CIDP as compared with OND. A significant increase of IL-6, IL-8 and IL-10 levels was found in pretreated VN. Both IL-7 and IL-8 levels correlated strongly with CSF protein levels in CIDP. although the correlation of IL-6 levels was weak. In CSF CD4+ T cells IFN-gamma(+) IL-4(+) cell percentages were markedly elevated in CIDP compared with OND, but not in VN. resulting in a significant increase of intracellular IFN-gamma/IL-4 ratio in CIDP, even in the absence of CSF pleocytosis. The nonresponders to intravenous immunoglobulins (IVIGs) showed a significantly lower IFN-gamma(-) IL-4(+) CD4+ T cell percentage, and tended to have a higher intracellular IFN-gamma/IL-4 ratio than the responders in CSF. Marked upregulation of Th1 cytokine, IL-17. and downregulation of Th2 cytokines, together with infiltration of IFN-gamma-producinq CD4+ T are useful markers for CIDP, while several Th2 cytokines are upregulated in VN in CSF. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 50 条
[21]   IL-6 in autoimmune disease and chronic inflammatory proliferative disease [J].
Ishihara, K ;
Hirano, T .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) :357-368
[22]  
Ito Hiroaki, 2003, Current Drug Targets - Inflammation and Allergy, V2, P125, DOI 10.2174/1568010033484296
[23]  
Jovanovic DV, 2000, ARTHRITIS RHEUM-US, V43, P1134, DOI 10.1002/1529-0131(200005)43:5<1134::AID-ANR24>3.0.CO
[24]  
2-#
[25]   Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10 [J].
Kieseier, BC ;
Tani, M ;
Mahad, D ;
Oka, N ;
Ho, T ;
Woodroofe, N ;
Griffin, JW ;
Toyka, KV ;
Ransohoff, RA ;
Hartung, HP .
BRAIN, 2002, 125 :823-834
[26]   IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis [J].
Kotake, S ;
Udagawa, N ;
Takahashi, N ;
Matsuzaki, K ;
Itoh, K ;
Ishiyama, S ;
Saito, S ;
Inoue, K ;
Kamatani, N ;
Gillespie, MT ;
Martin, TJ ;
Suda, T .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1345-1352
[27]   Association of the-2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis [J].
Lard, LR ;
van Gaalen, FA ;
Schonkeren, JJM ;
Pieterman, EJ ;
Stoeken, G ;
Vos, K ;
Nelissen, RGHH ;
Westendorp, RGJ ;
Hoeben, RC ;
Breedveld, FC ;
Toes, REM ;
Huizinga, TWJ .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1841-1848
[28]   Platelets and anticoagulant capacity in patients with inflammatory bowel disease [J].
Larsen, TB ;
Nielsen, JN ;
Fredholm, L ;
Lund, ED ;
Brandslund, I ;
Munkholm, P ;
Hey, H .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2002, 32 (02) :92-96
[29]   IL-10 and its related cytokines for treatment of inflammatory bowel disease [J].
Li, Ming-Cai ;
He, Shao-Heng .
WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (05) :620-625
[30]   PEGylated recombinant human tumor necrosis factor alpha: Pharmacokinetics and anti-tumor effects [J].
Li, YP ;
Pei, YY ;
Zhou, ZH ;
Zhang, XY ;
Gu, ZH ;
Ding, J ;
Gao, XJ ;
Zhu, JH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (06) :666-670